Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insmed Incorporated - Common Stock
(NQ:
INSM
)
150.68
+1.14 (+0.76%)
Streaming Delayed Price
Updated: 12:36 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
452,151
Open
149.77
Bid (Size)
150.48 (300)
Ask (Size)
150.87 (300)
Prev. Close
149.54
Today's Range
148.41 - 150.74
52wk Range
60.40 - 212.75
Shares Outstanding
115,246,666
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Performance
YTD
-14.9%
-14.9%
1 Month
-10.2%
-10.2%
3 Month
-21.5%
-21.5%
6 Month
+33.5%
+33.5%
1 Year
+92.9%
+92.9%
More News
Read More
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib
↗
January 06, 2026
Via
The Motley Fool
Topics
Stocks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
December 29, 2025
From
The Schall Law Firm
Via
Business Wire
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line
↗
December 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit
↗
December 17, 2025
Via
Stocktwits
Wondering what's happening in today's after-hours session?
↗
December 17, 2025
Via
Chartmill
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million?
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares?
↗
December 03, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
Via
MarketMinute
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
December 02, 2025
From
BioMedWire
Via
GlobeNewswire
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks
↗
November 30, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Billionaire Stanley Druckenmiller Just Bet Big on This Hot IPO Stock. Is It a Buy?
↗
November 23, 2025
Via
The Motley Fool
Topics
ETFs
Initial Public Offering
Regulatory Compliance
Peering Into Insmed Inc's Recent Short Interest
↗
November 18, 2025
Via
Benzinga
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves
↗
November 14, 2025
Via
Benzinga
If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today
↗
November 14, 2025
Via
Benzinga
This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash
↗
November 10, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High
↗
November 09, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
↗
October 31, 2025
Via
Benzinga
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
↗
October 30, 2025
Via
Benzinga
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
↗
October 30, 2025
Via
Benzinga
Topics
Economy
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports
↗
October 30, 2025
Via
Investor's Business Daily
Frequently Asked Questions
Is Insmed Incorporated - Common Stock publicly traded?
Yes, Insmed Incorporated - Common Stock is publicly traded.
What exchange does Insmed Incorporated - Common Stock trade on?
Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insmed Incorporated - Common Stock?
The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
What is the current price of Insmed Incorporated - Common Stock?
The current price of Insmed Incorporated - Common Stock is 150.68
When was Insmed Incorporated - Common Stock last traded?
The last trade of Insmed Incorporated - Common Stock was at 02/10/26 12:36 PM ET
What is the market capitalization of Insmed Incorporated - Common Stock?
The market capitalization of Insmed Incorporated - Common Stock is 17.36B
How many shares of Insmed Incorporated - Common Stock are outstanding?
Insmed Incorporated - Common Stock has 17B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
